Hengrui Medicine (01276.HK) spent 9.4537 million yuan on June 5 to repurchase 200,000 shares of A shares.

The Wise Finance APP reported that Hengrui Medicine (01276.HK) announced on June 5, 2026 that the company plans to repurchase 200,000 A shares at a cost of RMB 9.4537 million. The repurchase price is RMB 47.05-47.45 per share.